ReviewACR open rheumatology2021

Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial.

Jon T Giles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.